Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers

References

• Bai S, Ahsan F. (2009). Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin. Pharm Res 3:539–48
   Google Scholar
• Benson HAE. (2005). Transdermal drug delivery: penetration enhancement techniques. Curr Drug Del 2:23–33
   PubMedGoogle Scholar
• Brahma NS, Shyam BJ. (2008). Iontophoretic delivery of 5-fluorouracil through excised human stratum corneum. Drug Discov Ther 2:128–35
   PubMedGoogle Scholar
• Borowska K, Wołowiec S, Rubaj A, et al. (2012). Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene – in vivo study. Int J Pharm 426:280–3
   PubMed Web of Science ®Google Scholar
• Clara G, Angel C, Inmaculada G, et al. (2008). Laser treatments on skin enhancing and controlling transdermal delivery of 5-fluorouracil. Lasers Sur Med 40:6–12
   PubMed Web of Science ®Google Scholar
• Carla AMC, Angela MM. (2003). Encapsulation of 5-fluorouracil in liposomes for topical administration. Acta Sci Technol 25:53–61
   Google Scholar
• Chauhan AS, Sridevi S, Chalasani KB, et al. (2003). Dendrimer mediated transdermal delivery: enhanced bioavailability of indomethacin. J Control Release 3:335–43
   Google Scholar
• Chandra A, Sharma PK. (2008). Proniosome based drug delivery system of piroxicam. Afr J Pharm Pharmacol 2:184–90
   Web of Science ®Google Scholar
• Chandrashekar NS, Shobha Rani RH. (2008). Physicochemical and pharmacokinetic parameters in drug selection and loading for transdermal drug delivery. Indian J Pharm Sci 70:94–6
   PubMed Web of Science ®Google Scholar
• Chien YW. (1987). Transdermal therapeutic systems. In: Robinson JR, Lee VHL, eds. Controlled drug delivery. New York: Marcel Dekker Inc, 523–49
   Google Scholar
• Cloninger MJ. (2002). Biological applications of dendrimers. Curr Opin Chem Biol 6:742–8
   PubMed Web of Science ®Google Scholar
• Dhamecha DL, Rathi AA, Saifee M, et al. (2009). Drug vehicle based approaches of penetration enhancement. Int J Pharm Pharm Sci 1:24–36
   Google Scholar
• Diasio RB, Harris BE. (1989). Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 16:215–37
   PubMed Web of Science ®Google Scholar
• Diksha K, Bozena M. (2010). Percutaneous penetration modifiers and formulation effects: thermal and spectral analyses. AAPS PharmSciTech 11:1068–83
   PubMed Web of Science ®Google Scholar
• Devarakonda B, Otto DP, Judefeind A, et al. (2007). Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes. Int J Pharm 345:142–53
   PubMed Web of Science ®Google Scholar
• El Maghraby GMM, Williams AC, Barry BW. (2005). Drug interaction and location in liposomes: correlation with polar surface areas. Int J Pharm 292:179–85
   PubMed Web of Science ®Google Scholar
• Elka T, Lizette A. (1985). Effect of propylene glycol, azone and n-decylmethyl sulphoxide on skin permeation kinetics of 5-fluorouracil. Int J Pharm 27:89–98
   Google Scholar
• El-Sayed M, Ginski M, Rhodes C, Ghandehari H. (2002). Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release 3:355–65
   Google Scholar
• Filipowicz A, Wolowiec S. (2011). Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers. Int J Pharm 1:152–6
   Google Scholar
• Goette DK. (1981). Topical chemotherapy with 5-fluorouracil – a review. J Am Acad Dermatol 4:633–49
   PubMed Web of Science ®Google Scholar
• Howard DB, Kenneth BS. (1996). Transdermal delivery of 5-fluorouracil (5-FU) by 1-alkylcarbonyl-5-FU prodrugs. Int J Pharm 129:203–10
   Google Scholar
• Fang J, Chi-Feng H, Yi-Ping F, Te-Fu C. (2004). Transdermal iontophoresis of 5-fluorouracil combined with electroporation and laser treatment. Int J Pharm 270:241–9
   PubMed Web of Science ®Google Scholar
• Kannan RM, Perumal OP, Kannan S. (2005). Dendrimers and hyperbranched polymers in drug delivery. In: Labhateswar V, Pelecky L, eds. The biomedical applications of nanotechnology. New Jersey: Wiley Inc, 105–30
   Google Scholar
• Kumar JA, Pullakandam N, Prabhu SL, Gopal V. (2010). Transdermal drug delivery system: an overview. Int J Pharm Sci Rev Res 3:49–54
   Google Scholar
• Madishetti SK, Palem CR, Gannu R, et al. (2010). Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization. DARU 18:221–9
   PubMed Web of Science ®Google Scholar
• Marjukka TT, Servet B, Nadir B, et al. (1993). Enhanced delivery of 5-fluorouracil through shed snake skin by two new transdermal penetration enhancers. Int J Pharm 92:89–95
   Google Scholar
• Meidan VM, Walmsley AD, Docker MF, Irwin WJ. (1999). Ultrasound-enhanced diffusion into coupling gel during phonophoresis of 5-fluorouracil. Int J Pharm 185:205–13
   PubMed Web of Science ®Google Scholar
• Menjoge AR, Navath RS, Asad A, et al. (2010). Transport and biodistribution of dendrimers across human fetal membrane: implications for intravaginal administration of dendrimer-drug conjugates. Biomaterials 18:5007–21
   Google Scholar
• Mutalik S, Udupa N. (2002). Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin. Pharmazie 57:838–41
   PubMed Web of Science ®Google Scholar
• Mutalik S, Hewavitharana AK, Shaw PN, et al. (2009a). Development and validation of a reversed-phase high-performance liquid chromatographic method for quantification of peptide dendrimers in human skin permeation experiments. J Chromatogr B 29:3556–62
   Google Scholar
• Mutalik S, Parekh HS, Davies NM, Udupa N. (2009b). A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride. Drug Deliv 2:82–91
   Google Scholar
• Mutalik S, Parekh HS, Anissimov YG, et al. (2013). Iontophoresis-mediated transdermal permeation of peptide dendrimers across human epidermis. Skin Pharmacol Physiol 26:127–38
   PubMed Web of Science ®Google Scholar
• Mutalik S, Nayak UY, Kalra R, et al. (2012). Sonophoresis-mediated permeation and retention of peptide dendrimers across human epidermis. Skin Res Technol 1:101–17
   Google Scholar
• Na M, Yiyun C, Tongwen X, et al. (2006). Dendrimers as potential drug carriers. Part II- Prolonged delivery of ketoprofen by in vitro and in vivo studies. Eur J Med Chem 41:670–4
   PubMed Web of Science ®Google Scholar
• Niederhafner P, Sebestik J, Jezek J. (2005). Peptide dendrimers. J Pept Sci 11:757–88
   PubMed Web of Science ®Google Scholar
• Nikhil K, Dilip D, Jeetendra N, Kushal G. (2008). Effect of permeation enhancers on the release and permeation kinetics of meloxicam gel formulations through rat skin. Asian J Pharm Sci 3:193–9
   Google Scholar
• Parekh HS, Marano RJ, Rakoczy EP, et al. (2006). Synthesis of a library of polycationic lipid core dendrimers and their evaluation in the delivery of an oligonucleotide with hVEGF inhibition. Bioorg Med Chem 14:4775–80
   PubMed Web of Science ®Google Scholar
• Parekh HS. (2007). The advance of dendrimers: a versatile targeting platform for gene/drug delivery. Cur Pharm Des 27:2837–50
   Google Scholar
• Pathan IB, Setty CM. (2009). Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res 8:173–9
   Web of Science ®Google Scholar
• Raja MH, Ping Q, Gao Z. (1998). Penetration enhancing effect of tetrahydrogeraniol on the percutaneous absorption of 5-fluorouracil from gels in excised rat skin. J Control Release 55:297–302
   PubMed Web of Science ®Google Scholar
• Renata FVL, Collet JH, Bentley LB. (2000). Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone. Int J Pharm 2000:127–32
   Google Scholar
• Ritesh K, Anil P. (2007). Modified transdermal technologies: breaking the barriers of drug permeation via the skin. Trop J Pharm Res 6:633–44
   Web of Science ®Google Scholar
• Sharma N, Agarwal G, Rana AC, et al. (2011). A review: transdermal drug delivery system: a tool for novel drug delivery system. Int J Drug Dev Res 3:70–84
   Google Scholar
• Tiwary AK, Sapra B, Jain S. (2007). Innovations in transdermal drug delivery: formulations and techniques. Recent Pat Drug Deliv Formul 1:23–36
   PubMedGoogle Scholar
• Tsuji T, Sugai T. (1975). Topically administered fluorouracil in psoriasis. Arch Dermatol 105:208–12
   Google Scholar
• Vandamme TF, Brobeck L. (2005). Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Control Release 1:23–38
   Google Scholar
• Venuganti VVK, Perumal OP. (2008). Effect of poly(amidoamine) (PAMAM) dendrimer on the skin permeation of 5-fluorouracil. Int J Pharm 361:230–8
   PubMed Web of Science ®Google Scholar
• Wang Z, Itoh Y, Hosaka Y, et al. (2003). Novel transdermal drug delivery system with polyhydroxyalkanoate and starbust polyamidoamine dendrimer. J Biosci Bioeng 5:541–3
   Google Scholar
• Wang R, Yaw-Bin H, Pao-Chu W, et al. (2007). The effects of iontophoresis and electroporation on transdermal delivery of indomethacin evaluated in vitro and in vivo. J Food Drug Anal 15:126–32
   Web of Science ®Google Scholar
• Yamane MA, Williams AC, Barry BW. (1995). Effects of terpenes and oleic acid as skin penetration enhancers towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scanning calorimetry. Int J Pharm 116:237–51
   Web of Science ®Google Scholar
• Yiyun C, Na M, Tongwen X, et al. (2007). Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J Pharm Sci 96:595–602
   PubMed Web of Science ®Google Scholar